SY — Stock Film
STOCK FILMSCENE 1/11SY · $2.71
Stock Expert AI presents
SY
So-Young International Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
So-Young International Inc. What it actually does.

Operates an online platform for medical aesthetics and healthcare services. Facilitates reservations for various medical treatments. Now — the numbers.

on the stock market since 2019
2,348 employees
$355.6M market value
Revenue last year:
$221.3M
The loss that same year:
$35.2M
For every $1 it earns, the company spends $1.2.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$139.9M
DEBT: $44.8M
At this pace, that money lasts about 4 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE PRICE TAG
MARKET VALUE / ANNUAL SALES
1.6×

This company is not turning a profit, so the market is pricing its sales instead: 1.6× for every dollar of annual revenue.

Against companies in its own sector, it looks cheaper than 71% of them.

Analysts' average target sits 70% below today's price.

What executives did with their own stock over the last 12 months:
6 buy6 sell

Buys and sells are dead even — no clear signal either way.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
59
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
29
very weak

Clearly below the class average.

VALUATION
71
strong

Clearly above the class average — a step short of the very top.

GROWTH
46
weak

Clearly below the class average.

PRICE MOMENTUM
50
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 54% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
The product is selling

Sales run at $221.3M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/2
Strong cash, light debt

There is $139.9M in the vault; even if every debt were paid off, $95.1M would remain.

1
THE RISKS · 1/3
Running at a loss

A loss of $35.2M against $221.3M in annual sales.

2
THE RISKS · 2/3
A wildly swinging price

This stock swings about 2.1 times as much as the market average. Big rallies — and big drops — can both happen fast.

3
THE RISKS · 3/3
The price sits above analysts’ target

The stock trades 70% above the average analyst price target.

FINALE · THE GRADE
D
34 / 100 · MoonshotScore

On our five-subject report card, SY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: SY is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film